Management of the lower urinary tract symptoms [LUTS] due to benign prostatic hyperplasia [BPH], with terazosin

R.M., Mubeen; N., Ahmad; M., Shahzad; M., Nawaz; M., Akbar

R.M., Mubeen; N., Ahmad; M., Shahzad; M., Nawaz; M., Akbar.

Annals of King Edward Medical College. 2005; 11 (4): 558-560

in En | IMEMR | ID: emr-69735

Responsible library: EMRO

Subject(s)

Humans; Male; Prostatic Hyperplasia/complications; Urinary Retention; Urinary Tract Infections; Hematuria; Adrenergic Antagonists; Urological Manifestations; Prazosin/analogs & derivatives

Search on Google

Add to My VHL

XML

Index: IMEMR Main subject: Prostatic Hyperplasia / Urinary Tract Infections / Prazosin / Urinary Retention / Adrenergic Antagonists / Urological Manifestations / Hematuria Limits: Humans / Male Language: En Journal: Ann. King Edward Med. Coll. Year: 2005

Search on Google

Add to My VHL

XML